Leadership Overview
Proxima Research International has 6 executives leading key functions including strategy, information technology, revenue generation, operations, human capital, and finance.
Driven by innovation in pharmaceuticals, Proxima Research International is dedicated to advancing healthcare solutions and achieving significant market impact through expert leadership and strategic vision.
Driven by innovation in pharmaceuticals, Proxima Research International is dedicated to advancing healthcare solutions and achieving significant market impact through expert leadership and strategic vision.
Leadership Roles at Proxima Research International
Oleksandr Khraban - Chief Executive Officer
Oleksandr Khraban, the Chief Executive Officer at Proxima Research International, directs the company's overall strategic direction and operational execution within the pharmaceuticals sector. This leadership role involves guiding Proxima Research International's expansion efforts across its international markets, ensuring alignment with the company's mission to advance healthcare solutions. The Chief Executive Officer oversees the integration of research and development initiatives with market demands, fostering an environment of continuous innovation. Oleksandr Khraban is responsible for setting long-term objectives and ensuring the company's financial health and sustainable growth. This executive drives the company's vision, managing stakeholder relationships and positioning Proxima Research International as a leader in its field. The Chief Executive Officer's purview includes all major business units, ensuring cohesive strategy implementation across all operational geographies.
Oleksii Bedun - Group Chief Financial Officer
Oleksii Bedun, the Group Chief Financial Officer at Proxima Research International, oversees the company's financial planning, reporting, and capital management strategies. This executive is responsible for ensuring the financial integrity and stability of the organization, managing budgets, and optimizing financial performance across all business units. The Group Chief Financial Officer directs investment strategies, risk management, and compliance with financial regulations in the pharmaceutical sector. Oleksii Bedun provides critical financial insights to support strategic decision-making and drive sustainable revenue growth. This leadership role involves managing relationships with investors, lenders, and financial institutions. The Group Chief Financial Officer's expertise is essential for navigating the complex financial landscape and securing the resources needed for Proxima Research International's ongoing research and development.
Nataliya Tadeyeva - Chief Operating Officer (Up To 600 Employees In 5 Countries)
Nataliya Tadeyeva, the Chief Operating Officer (Up To 600 Employees In 5 Countries) at Proxima Research International, manages the day-to-day operational execution and efficiency across the company's global footprint. This role involves overseeing supply chain logistics, manufacturing processes, and quality control to ensure the consistent delivery of pharmaceutical products. The Chief Operating Officer (Up To 600 Employees In 5 Countries) focuses on optimizing resource allocation and streamlining workflows to enhance productivity and reduce operational costs. Nataliya Tadeyeva ensures compliance with international regulatory standards and industry best practices across all five countries of operation. This executive drives operational excellence, fostering a culture of continuous improvement and accountability. The Chief Operating Officer (Up To 600 Employees In 5 Countries) plays a vital part in scaling operations to support company growth and market penetration.
Artem Andruschenko - Chief Information Officer
Artem Andruschenko, the Chief Information Officer at Proxima Research International, architects and manages the company's comprehensive technology infrastructure and digital strategy. This critical role ensures the secure and efficient operation of all IT systems, supporting Proxima Research International's pharmaceutical research and development activities. The Chief Information Officer oversees the implementation of advanced data analytics and cybersecurity measures, safeguarding sensitive research data and intellectual property. Artem Andruschenko drives digital transformation initiatives, enhancing operational efficiency and enabling data-driven decision-making across all departments. This executive is responsible for evaluating and adopting emerging technologies that can accelerate drug discovery and streamline business processes. The Chief Information Officer ensures robust IT support for global operations, facilitating seamless collaboration among research teams and international partners.
Evgeniy Kunda - Chief Revenue Officer
Evgeniy Kunda, the Chief Revenue Officer at Proxima Research International, spearheads all revenue-generating activities and commercial strategies for the organization. This executive directs global sales operations, business development, and market expansion initiatives within the competitive pharmaceutical landscape. The Chief Revenue Officer focuses on optimizing sales funnels, identifying new market opportunities, and building strong client relationships to drive consistent revenue growth. Evgeniy Kunda collaborates closely with research and development teams to align commercial strategies with product pipelines and market needs. This leadership position involves setting aggressive revenue targets and implementing effective sales methodologies across all regions. The Chief Revenue Officer's efforts are crucial for enhancing Proxima Research International's market share and financial performance.
Anatolii Shapovalov - Chief Human Resources Officer
Anatolii Shapovalov, the Chief Human Resources Officer at Proxima Research International, directs all aspects of human capital management and organizational development. This executive is responsible for attracting, retaining, and developing top talent within the highly specialized pharmaceutical industry. The Chief Human Resources Officer oversees the implementation of comprehensive HR policies, compensation strategies, and employee engagement programs designed to foster a high-performance culture. Anatolii Shapovalov ensures that Proxima Research International's workforce is equipped with the necessary skills and resources to meet the company's strategic objectives. This leadership role involves managing talent acquisition across international locations and promoting diversity and inclusion throughout the organization. The Chief Human Resources Officer's strategic initiatives are fundamental to supporting Proxima Research International's growth and innovation.
Explore Leadership Teams in Manufacturing
Regeneron is a biotechnology company that discovers, develops, and commercializes innovative medicines for serious diseases. The company focuses on using advanced science and proprietary technologies to create life-changing treatments for conditions such as cancer, eye diseases, inflammatory disorders, and rare diseases.
Company Leadership
WN
VE
Bausch Health Companies Inc. operates as a global pharmaceutical and healthcare products company focused on developing, manufacturing, and marketing a broad portfolio of branded pharmaceuticals, generic medicines, over-the-counter healthcare products, and medical devices. The organization works to improve patient health outcomes by delivering therapeutic solutions across multiple medical specialties. Through its research, development, and commercial operations, the company serves healthcare providers, hospitals, pharmacies, and patients across numerous international markets. The company functions as a diversified healthcare enterprise with business segments that address several therapeutic and medical device categories. Its core focus areas include gastroenterology, hepatology, neurology, dermatology, dentistry, medical aesthetics, and ophthalmology. By maintaining a broad therapeutic portfolio, the organization supports healthcare professionals in diagnosing, managing, and treating a wide range of medical conditions that affect millions of patients globally.
Company Leadership
TU
JS
Integrace Health is a therapy-focused healthcare company based in India, specializing in innovative solutions for Musculoskeletal Disorders, Pain Management, and Women's Health. Founded in 2018, it has quickly risen to become one of India's top 70 pharmaceutical companies, with five brands ranked #1 in their respective therapy areas. The company aims to significantly impact the health and well-being of the Indian population and envisions becoming a transformative force in the healthcare landscape by 2030. Integrace Health is committed to innovation, disciplined execution, and inspiring collaboration among its stakeholders.
Company Leadership KR
SS
AA
AN
Torrent Pharmaceuticals Ltd is the flagship enterprise of the Torrent Group and stands among the leading pharmaceutical companies in India, with a strong and growing international presence. The company is widely recognized for its leadership across key therapeutic areas, including cardiovascular health, central nervous system disorders, gastro-intestinal care, vitamins, minerals and nutritionals, and cosmo-dermatology, while also maintaining a meaningful footprint in diabetology, pain management, gynaecology, oncology and anti-infective treatments. Built on a foundation of scientific excellence and innovation, Torrent Pharma places research and development at the core of its strategy, supported by advanced infrastructure and a highly skilled scientific workforce dedicated to developing high-quality, affordable medicines for patients worldwide.
Company Leadership SM
HP
VG
AV
Frequently Asked Questions Regarding Proxima Research International Top Executives and Leadership Team
